Neurocrine (NBIX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Interim results from a study in China suggest ivonescimab may reduce the risk of death versus Keytruda, but the difference ...

Gufic BioSciences Ltd., incorporated in the year 1984, is a Small Cap company (having a market cap of Rs 3,647.59 Crore) operating in Pharmaceuticals sector. Gufic BioSciences Ltd. key ...

Alvista Biosciences Private Limited is an Indian Non-Government Company. It's a private company and is classified as'company limited by shares'. Company's authorized capital stands at Rs 1.0 lakhs and ...